EPIGENETICS PHARMA LLC has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are IDENIX PHARMACEUTICALS INC, NUCANA BIOMED LTD and NuCana plc.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Canada | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | China | 2 | |
#6 | Australia | 1 | |
#7 | Hong Kong | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Daifuku Richard | 18 |
#2 | Sergueev Dmitri S | 10 |
#3 | Gall Anna Stanislav | 6 |
Publication | Filing date | Title |
---|---|---|
CN109152791A | The method of -2 ' of the fluoro- 5- azepine of 2 ', 2 '-two-deoxycytidine or its prodrug treatment TP53 wild type tumor | |
CA2963686A1 | Silylated pyrimidine prodrugs and methods of their use | |
US2017298088A1 | Vitamin E-nucleoside prodrugs | |
EP2970359A1 | Fluorinated pyrimidine analogs and methods of use thereof |